76-90 of 304
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiersExamining the Correlation Between HIV & Neurocognitive Disorders
Jerome Lisk, MD, MBA, M.S., FAAN
Santosh Kumar, PhD
Identifying Cardiovascular Risk Factors for HIV Patients
Heart MattersIdentifying Cardiovascular Risk Factors for HIV Patients
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Steve Grinspoon, MD
Investigating CAR T-Cell Therapy for HIV Treatment
Clinician's RoundtableInvestigating CAR T-Cell Therapy for HIV Treatment
mAB Treatment for COVID-19 Does Not Impact HDP Rates
Advances in Women's HealthmAB Treatment for COVID-19 Does Not Impact HDP Rates
Stopping Stigma Surrounding Monkeypox with Provider Education
NeuroFrontiersStopping Stigma Surrounding Monkeypox with Provider Education
How Different Types of Influenza Vaccines Are Made
VacciNationHow Different Types of Influenza Vaccines Are Made
Jason Goldman, MD
- advertisement
The Aging HIV Population: Combatting Challenges & Addressing Stigma
Clinician's RoundtableThe Aging HIV Population: Combatting Challenges & Addressing Stigma
Charles Turck, PharmD, BCPS, BCCCP
Andrew Clark, MD
Tackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
COVID-19: On The FrontlinesTackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
Jennifer Caudle, DO, FACOFP
Jennifer Shu, MD, FAAP
A Debate on Dosing Considerations: Perspectives on Antimicrobials
IDSA Action CenterA Debate on Dosing Considerations: Perspectives on Antimicrobials
Charles Turck, PharmD, BCPS, BCCCP
Fatima, Adhi, MD
Mei Chang, PharmD
Looking Back to Look Ahead: Lessons Learned from the Monkeypox Outbreak
IDSA Action CenterLooking Back to Look Ahead: Lessons Learned from the Monkeypox Outbreak
Charles Turck, PharmD, BCPS, BCCCP
Jason Zucker, MD
Can Generic Drugs Be Repurposed for COVID-19 Treatment?
Diabetes DiscourseCan Generic Drugs Be Repurposed for COVID-19 Treatment?
John Buse, MD, PhD
Carolyn Bramante
Updates in Vaccination: Insights from IDWeek
IDSA Action CenterUpdates in Vaccination: Insights from IDWeek
- advertisement
Key COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
IDSA Action CenterKey COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
Emerging Data on HIV: Updates from Poster Sessions at IDWeek
IDSA Action CenterEmerging Data on HIV: Updates from Poster Sessions at IDWeek
Anticipated Updates in HIV: A Look Ahead at IDWeek
IDSA Action CenterAnticipated Updates in HIV: A Look Ahead at IDWeek
